ALC Fair Value — Alcon AG

Medical Devices · Institutional-depth multi-model valuation on Equity Rank

Current Price
$75.35
Consensus Fair Value
$78.34
Margin of Safety
4.0%

How ALC's valuation models agree

Equity Rank computed model fair value for ALC from 9 independent valuation methods with sufficient data. 5 place fair value above the current price of $75.35, and 4 place it below. The model-blended estimate lands at $78.34 — a model fair value differential of 4.0% above the current price under these model assumptions. The larger group corresponds to potential undervaluation versus the current price.

Models: FV above price
5
Models: FV below price
4
Models compared
9

Each method (DCF, Graham Number, EPV, Three-Stage DCF, DDM, Residual Income, Justified Price-to-Book, and more) is weighted by historical sector accuracy. Model-derived and informational only — not investment advice.

ALC fundamental profile

Equity Rank's fundamental strength composite scores ALC at 66.4/100 (B, Solid), blending profitability, balance-sheet, and cash-flow quality. Over the trailing three years, free cash flow has compounded at +50.5% per year and gross margin has moved +0.8 pp. Its SAVE composite score has moved +0.1 over the past 30 days.

A composite quality metric for research context — not a rating, recommendation, or directional signal.

About ALC

Alcon AG (ALC) is analyzed on Equity Rank using the S·A·V·E framework: Sentiment, Analyst consensus, Valuation (DCF, Graham, multiples), and Earnings quality. The consensus fair value is a blend of multiple models designed to surface potential mispricings versus current market price.

Equity Rank provides institutional-depth valuation research on 3,000+ US equities. Data is refreshed daily and combines quantitative models with AI-driven qualitative analysis.

Related Medical Devices Research

JNJ · UNH · PFE · ABBV · MRK

All Healthcare stocks with model fair values · Undervalued Healthcare stocks

Research Tools

Intrinsic Value Calculator · DCF Calculator · Margin of Safety Calculator

Data study: 19 valuation models across 3,091 US stocks · Compare any two stocks